MedicinePOM

Nilotinib

Nilotinib is a targeted cancer tablet for Philadelphia chromosome-positive chronic myeloid leukaemia.

Clinical information

Common uses

chronic myeloid leukaemia (Ph+ CML)

Common side effects

feeling sick
rash
headache
tiredness
itching

Cautions

boxed warning: dangerous heart rhythm changes; sudden deaths reported
not for people with low potassium/magnesium or long QT syndrome
regular ECGs and blood monitoring needed
can harm an unborn baby — use effective contraception

Interactions

strong CYP3A inhibitors — avoid or reduce dose
strong CYP3A inducers — avoid
other QT-prolonging medicines — avoid

Pregnancy: can harm an unborn baby — avoid

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, nilotinib (Cavhanza) label, setid 98b197ea-bca4-427e-8737-97f70a3262bc (accessed 2026-08-16)

Approved brands & formulations2

Brand name	Dosage form	Strength	Importer	Category
Tasigna	Capsule	200 mg	Mediquip Maldives Pvt. Ltd	POM
Tasigna	Capsule	150 mg	Mediquip Maldives Pvt. Ltd	POM